| Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy (NCT00579150) | AstraZeneca | 2009-01-01 |
| Diabetes Self-Management Models to Reduce Health Disparities (NCT01221090) | Scott and White Hospital & Clinic | 2009-01-01 |
| Resveratrol in Type2 Diabetes and Obesity (NCT01158417) | University at Buffalo | 2008-12-01 |
| Metformin Treatment in Gestational Diabetes and Noninsulin Dependent Diabetes in Pregnancy in a Developing Country (NCT01855763) | Dow University of Health Sciences | 2008-12-01 |
| Effects of Resveratrol in Patients With Type 2 Diabetes (NCT01677611) | Khoo Teck Puat Hospital | 2008-12-01 |
| Multicentric Evaluation of Two Telematics Systems in Type 2 Diabetic Patients in Failure of Oral Treatment and Having to Start Treatment by Basal Insulin (NCT00937703) | Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | 2008-12-01 |
| Using Conversation Maps to Reinforce Self-Care (NCT00895986) | Joslin Diabetes Center | 2008-12-01 |
| Metabolic Effects of Vitamin D in Patients With Type 2 Diabetes (NCT00812578) | University of Aarhus | 2008-12-01 |
| Glycemic Response to Momordica Charantia in Type 2 Diabetes (NCT00823953) | Services Hospital, Lahore | 2008-11-01 |
| Diabetes Scorecard Educational Intervention Study (NCT01339520) | George Washington University | 2008-11-01 |
| Beta-Cell Dysfunction and Insulin Resistance Among Italian Patients With Type 2 Diabetes (MK-0000-113) (NCT01472341) | Merck Sharp & Dohme LLC | 2008-11-01 |
| To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension (NCT00790153) | AstraZeneca | 2008-11-01 |
| Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes (NCT00803660) | AstraZeneca | 2008-11-01 |
| Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant (NCT00788827) | Imperial College London | 2008-11-01 |
| LUPS-Lipids and Glucose Under Prospective Surveillance (NCT01313156) | Asklepios proresearch | 2008-11-01 |
| Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus (NCT00797186) | University of Virginia | 2008-11-01 |
| Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin (NCT00757588) | AstraZeneca | 2008-11-01 |
| Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus (NCT00765817) | AstraZeneca | 2008-10-01 |
| Short-term Effect of Intensive Insulin Therapy on Incretin Secretion (NCT00776243) | The Catholic University of Korea | 2008-10-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245 (8245-004)(COMPLETED) (NCT00790556) | Merck Sharp & Dohme LLC | 2008-10-01 |
| To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin (NCT00774553) | AstraZeneca | 2008-10-01 |
| Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes (NCT00736515) | Servier (Tianjin) Pharmaceutical Co. LTD. | 2008-10-01 |
| Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder (NCT01798914) | Mannkind Corporation | 2008-10-01 |
| A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED) (NCT00912002) | Merck Sharp & Dohme LLC | 2008-10-01 |
| Chronotherapy with Low-dose Aspirin for Primary Prevention (NCT00725127) | University of Vigo | 2008-10-01 |
| Exercise Intensity and Type 2 Diabetics (NCT01356953) | Catholic University of Brasília | 2008-10-01 |
| Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass (NCT00775684) | University of Pennsylvania | 2008-10-01 |
| Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin (NCT00770302) | AstraZeneca | 2008-10-01 |
| To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin (NCT00768105) | AstraZeneca | 2008-09-01 |
| Bronx A1c: Bring it Down for Health (NCT00797888) | Albert Einstein College of Medicine | 2008-09-01 |
| Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients (NCT00854503) | University of Rome Tor Vergata | 2008-09-01 |
| Training, Detraining, Retraining and Glycemic Control in Patients With Type 2 Diabetes (NCT01580475) | Democritus University of Thrace | 2008-09-01 |
| Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1 (NCT01930448) | St. Luke's-Roosevelt Hospital Center | 2008-09-01 |
| A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED) (NCT00758680) | Merck Sharp & Dohme LLC | 2008-08-01 |
| TODAY Genetics Study (NCT00722397) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2008-08-01 |
| Almonds and Diabetes Management (NCT01161030) | Arizona State University | 2008-08-01 |
| Bone Turnover in Type 2 Diabetes Patients (NCT00732121) | University of Vermont | 2008-08-01 |
| "Information Technology Methodology for Patient Motivation in Diabetes Management." (NCT00727896) | India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | 2008-08-01 |
| Changes in Ectopic Fat Following Surgically Induced Weight Loss (NCT00840307) | University of Texas Southwestern Medical Center | 2008-08-01 |
| Basal Insulin for Type 2 Diabetes Patients Treated in Outpatient Clalit Clinics (NCT00726674) | Sanofi | 2008-08-01 |
| Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes (NCT00481117) | Eli Lilly and Company | 2008-08-01 |
| A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081) (NCT00730275) | Merck Sharp & Dohme LLC | 2008-07-18 |
| The Effect of Vinegar on Glucose and Lipid Metabolism in Subjects With Impaired Glucose Tolerance or Type 2 Diabetes (NCT02309424) | Attikon Hospital | 2008-07-01 |
| Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone (NCT00683657) | AstraZeneca | 2008-07-01 |
| Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes (NCT00790348) | Wayne State University | 2008-07-01 |
| Sleep Loss and Glucose Metabolism in People With Family History of Type 2 Diabetes. (NCT00721019) | University of Chicago | 2008-07-01 |
| Comparative Study of Implant Surfaces to Enhance Stabilization in Patients With Type 2 Diabetes (NCT01142297) | The University of Texas Health Science Center at San Antonio | 2008-07-01 |
| Antioxidant Treatment of Type 2 Diabetes (NCT00609102) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2008-07-01 |
| Vitamin D, Glucose Control and Insulin Sensitivity in African-Americans (NCT00784511) | Tufts University | 2008-07-01 |
| Glucose Metabolism and Sleep in People With Family History of Type 2 Diabetes. (NCT00720889) | University of Chicago | 2008-07-01 |
| Add-on to Thiazolidinedione (TZD) Failures (NCT00683878) | AstraZeneca | 2008-07-01 |
| Risk of Hypoglycemia in Type 2 Diabetes (NCT00734669) | University of Giessen | 2008-07-01 |
| Fitness and Sleep in People With Family History of Type 2 Diabetes. (NCT00721084) | University of Chicago | 2008-07-01 |
| VA NEPHRON-D: Diabetes iN Nephropathy Study (NCT00555217) | US Department of Veterans Affairs | 2008-07-01 |
| Sleep Loss and Energy Metabolism in People With Family History of Type 2 Diabetes. (NCT00724087) | University of Chicago | 2008-07-01 |
| Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control (NCT00698932) | AstraZeneca | 2008-06-01 |
| Effects of Berries and Berry Fractions on Metabolic Diseases (NCT01860547) | University of Turku | 2008-06-01 |
| Is it Possible to Screen for Type 2 Diabetes at Day 2 in Gestational Diabetes Mellitus Patients Postpartum? (NCT00921882) | Université de Sherbrooke | 2008-06-01 |
| The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes (NCT00699426) | Lise Tarnow | 2008-06-01 |
| An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets (NCT00643851) | AstraZeneca | 2008-06-01 |
| A Specialized Diet for the Unique Metabolic Characteristics of Peripubertal African American Girls (NCT00718874) | University of Alabama at Birmingham | 2008-06-01 |
| Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress (NCT00699322) | The Catholic University of Korea | 2008-06-01 |
| Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes (NCT00699023) | Federico II University | 2008-06-01 |
| Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes (NCT00658021) | AstraZeneca | 2008-05-30 |
| Effect of Alcohol on Cephalic Phase Reflex and Gene Expression (NCT00652405) | TNO | 2008-05-01 |
| What Makes Exercise Feel More Difficult to Women With and Without Type 2 Diabetes (NCT00785005) | University of Colorado, Denver | 2008-05-01 |
| Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes (NCT00991055) | National Cheng-Kung University Hospital | 2008-05-01 |
| Effects of Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients (NCT00682149) | Yeditepe University Hospital | 2008-05-01 |
| Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes (NCT00698789) | Incyte Corporation | 2008-05-01 |
| A Diabetes Study to Treat A Population Previously Not at Target (NCT00747149) | AstraZeneca | 2008-05-01 |
| Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes (NCT00786019) | University of Colorado, Denver | 2008-05-01 |
| 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics (NCT00654745) | Daiichi Sankyo | 2008-05-01 |
| VLDL-triglyceride Kinetics in Type 2 Diabetes (NCT01037647) | University of Aarhus | 2008-05-01 |
| The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients (NCT00643773) | Maastricht University Medical Center | 2008-05-01 |
| Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin (NCT00673231) | AstraZeneca | 2008-04-01 |
| REACH-OUT: Chicago Children's Diabetes Prevention Program (NCT00723853) | University of Chicago | 2008-04-01 |
| Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus. (NCT00849576) | Biodel | 2008-04-01 |
| Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control (NCT00806520) | HealthPartners Institute | 2008-04-01 |
| Type 2 Diabetes and Exercise - A Pilot Study (NCT00666861) | Bayside Health | 2008-04-01 |
| The Copenhagen Insulin and Metformin Therapy Trial (NCT00657943) | Steno Diabetes Center Copenhagen | 2008-04-01 |
| Copenhagen Obesity Risk Assessment Study (NCT00655902) | University of Copenhagen | 2008-04-01 |
| 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D) (NCT00666458) | AstraZeneca | 2008-04-01 |
| Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients (NCT00680745) | AstraZeneca | 2008-04-01 |
| Acute Effect of Intensive Insulin Infusion on Intestinal Triglyceride-rich-lipoprotein-apoB48 Metabolism in Type 2 Diabetic Patients (NCT00950209) | Assistance Publique Hopitaux De Marseille | 2008-04-01 |
| Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes (NCT01449773) | Laval University | 2008-04-01 |
| Impact of Mulberry Leaf on Type 2 Diabetes (NCT00795704) | University of Mississippi Medical Center | 2008-04-01 |
| Exeantide in Type 2 Diabetes on Insulin (NCT01154933) | University at Buffalo | 2008-04-01 |
| Burden of Chronic Kidney Disease (CKD), Type 2 Diabetes Mellitus (T2DM), and Comorbid T2DM/CKD in Alberta, Canada (NCT04417725) | Medlior Health Outcomes Research Ltd | 2008-04-01 |
| Effects of Glutamine on GLP-1 and Insulin Secretion in Man (NCT00673894) | Garvan Institute of Medical Research | 2008-04-01 |
| Changes of Biomarkers in Response to Training and Antioxidant Treatment (NCT00638560) | University of Leipzig | 2008-03-01 |
| Necessity for Lipid Lowering Therapy in Type 2 Diabetes Patients (NCT00639080) | Endocrine Research Society | 2008-03-01 |
| The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia (NCT00639613) | University Hospital, Gentofte, Copenhagen | 2008-03-01 |
| Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients (NCT00660907) | AstraZeneca | 2008-03-01 |
| The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects (NCT00659711) | University at Buffalo | 2008-03-01 |
| Remote Monitoring in Diabetes Disease Management (NCT00675311) | LifeScan | 2008-03-01 |
| Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes (NCT00922649) | Animas Corporation | 2008-02-01 |
| Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients (NCT00808860) | Hanoi Medical University | 2008-02-01 |
| Effects of 3 Months of Supervised Exercise Training (NCT01349166) | University Hospital, Clermont-Ferrand | 2008-02-01 |
| Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes (NCT01435980) | Wu Qinan | 2008-02-01 |
| DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery (NCT00641251) | Medtronic - MITG | 2008-02-01 |